These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26161142)

  • 21. Improved lower urinary tract symptoms after robot-assisted radical prostatectomy: implications for survivorship, treatment selection and patient counselling.
    Ahn T; Roberts MJ; Strahan A; Malone G; Paterdis J; Wood G; Heathcote P
    BJU Int; 2019 May; 123 Suppl 5():47-53. PubMed ID: 31012991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Do baseline estrogen and testosterone affect lower urinary tract symptoms (LUTS) prior to or after pharmacologic treatment with tadalafil?
    Egan KB; Miner MM; Suh M; McVary K; Ni X; Roehrborn CG; Wittert G; Wong DG; Rosen RC
    Andrology; 2015 Nov; 3(6):1165-72. PubMed ID: 26452447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severity of lower urinary tract symptoms reflects different composition of bladder storage dysfunction and bladder outlet obstruction in men with symptomatic benign prostatic hyperplasia.
    Jhang JF; Liao CH; Kuo HC
    Int J Clin Pract; 2014 Jun; 68(6):743-8. PubMed ID: 24471413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of lower urinary tract symptoms in men by international prostate symptom score and core lower urinary tract symptom score.
    Fujimura T; Kume H; Nishimatsu H; Sugihara T; Nomiya A; Tsurumaki Y; Miyazaki H; Suzuki M; Fukuhara H; Enomoto Y; Homma Y
    BJU Int; 2012 May; 109(10):1512-6. PubMed ID: 21883834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Menorrhagia and Uterine Volume Associated with Lower Urinary Tract Symptoms in Patients with Adenomyosis.
    Li T; Xu XX; Dai Y; Zhang JJ; Lang JH; Leng JH
    Chin Med J (Engl); 2017 Jul; 130(13):1552-1556. PubMed ID: 28639570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of a hexanic extract of Serenoa repens (Permixon
    Vela-Navarrete R; Alcaraz A; Rodríguez-Antolín A; Miñana López B; Fernández-Gómez JM; Angulo JC; Castro Díaz D; Romero-Otero J; Brenes FJ; Carballido J; Molero García JM; Fernández-Pro Ledesma A; Cózar Olmos JM; Manasanch Dalmau J; Subirana Cachinero I; Herdman M; Ficarra V
    BJU Int; 2018 Dec; 122(6):1049-1065. PubMed ID: 29694707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors predicting progression to castrate-resistant prostate cancer in patients with advanced prostate cancer receiving long-term androgen-deprivation therapy.
    de la Taille A; Martínez-Piñeiro L; Cabri P; Houchard A; Schalken J;
    BJU Int; 2017 Jan; 119(1):74-81. PubMed ID: 26919403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The visual prostate symptom score is a simple tool to identify and follow up in general practice patients with lower urinary tract symptoms associated with benign prostatic hyperplasia (a study with 1359 patients).
    Descazeaud A; Coloby P; Taille A; Karsenty G; Kouri G; Rossi D; Carrois F; Zerbib M
    Presse Med; 2018; 47(7-8 Pt 1):e91-e98. PubMed ID: 30075950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of tadalafil 5 mg once daily for lower urinary tract symptoms suggestive of benign prostatic hyperplasia: subgroup analyses of pooled data from 4 multinational, randomized, placebo-controlled clinical studies.
    Porst H; Oelke M; Goldfischer ER; Cox D; Watts S; Dey D; Viktrup L
    Urology; 2013 Sep; 82(3):667-73. PubMed ID: 23876588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of the international prostate symptoms scores for patients with lower urinary tract symptoms: A descriptive cross-sectional study.
    Gyasi-Sarpong CK; Acheampong E; Yeboah FA; Aboah K; Laing EF; Amoah G
    Urol Ann; 2018; 10(3):317-323. PubMed ID: 30089993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study.
    Sacco E; Bientinesi R; Marangi F; Totaro A; D'Addessi A; Racioppi M; Pinto F; Vittori M; Bassi P
    BJU Int; 2012 Dec; 110(11 Pt C):E837-44. PubMed ID: 22712582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score.
    Kaplan SA; Roehrborn CG; Chancellor M; Carlsson M; Bavendam T; Guan Z
    BJU Int; 2008 Nov; 102(9):1133-9. PubMed ID: 18510659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Do Lifestyle Factors Affect Lower Urinary Tract Symptoms? Results from the Korean Community Health Survey.
    Kim KS; Jo JK; Lee JA; Choi BY; Moon HS
    Int Neurourol J; 2019 Jun; 23(2):125-135. PubMed ID: 31260612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tolterodine extended release with or without tamsulosin in men with lower urinary tract symptoms including overactive bladder symptoms: effects of prostate size.
    Roehrborn CG; Kaplan SA; Jones JS; Wang JT; Bavendam T; Guan Z
    Eur Urol; 2009 Feb; 55(2):472-9. PubMed ID: 18583022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men.
    Debruyne FM; Behre HM; Roehrborn CG; Maggi M; Wu FC; Schröder FH; Jones TH; Porst H; Hackett G; Wheaton OA; Martin-Morales A; Meuleman E; Cunningham GR; Divan HA; Rosen RC;
    BJU Int; 2017 Feb; 119(2):216-224. PubMed ID: 27409523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Effect of Tamsulosin Treatment on Erectile Functions in Patients with Lower Urinary Tract Symptoms (LUTS) due to Benign Prostate Hyperplasia: Correlation between Improvement of LUTS and Erectile Function.
    Matsushita T; Hasegawa T; Nakano M; Tanaka T; Iwamoto T
    Low Urin Tract Symptoms; 2011 Apr; 3(1):15-8. PubMed ID: 26676346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural history of lower urinary tract symptoms in Japanese men from a 15-year longitudinal community-based study.
    Fukuta F; Masumori N; Mori M; Tsukamoto T
    BJU Int; 2012 Oct; 110(7):1023-9. PubMed ID: 22233355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized Controlled Trial to Assess the Efficacy of the Combination Therapy of Alfuzosin and Tadalafil in Patients with Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia.
    Kumar S; Kondareddy C; Ganesamoni R; Nanjappa B; Singh SK
    Low Urin Tract Symptoms; 2014 Jan; 6(1):35-40. PubMed ID: 26663498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronoradiation Therapy for Prostate Cancer: Morning Proton Beam Therapy Ameliorates Worsening Lower Urinary Tract Symptoms.
    Negoro H; Iizumi T; Mori Y; Matsumoto Y; Chihara I; Hoshi A; Sakurai H; Nishiyama H; Ishikawa H
    J Clin Med; 2020 Jul; 9(7):. PubMed ID: 32708724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The natural history of lower urinary tract symptoms over five years.
    Temml C; Brössner C; Schatzl G; Ponholzer A; Knoepp L; Madersbacher S;
    Eur Urol; 2003 Apr; 43(4):374-80. PubMed ID: 12667718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.